Insider Title Company Date Price Return Shares Value
Shah Sujal Chief Executive Officer CymaBay Therapeutics, Inc. (CBAY) 2022-06-06 $1.95 1565.6% 51,301 $100,037
Return Profit / (loss) Cost
Total 1565.6% $1,566,220 $100,037